Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

1.

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease.

Cantarini L, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Anelli MG, Franceschini R, Menicacci C, Galeazzi M, Selmi C, Rigante D.

Autoimmun Rev. 2014 Aug 22. pii: S1568-9972(14)00152-9. doi: 10.1016/j.autrev.2014.08.008. [Epub ahead of print] Review.

PMID:
25151975
[PubMed - as supplied by publisher]
2.

Untangling the Web of Systemic Autoinflammatory Diseases.

Rigante D, Lopalco G, Vitale A, Lucherini OM, Caso F, De Clemente C, Molinaro F, Messina M, Costa L, Atteno M, Laghi-Pasini F, Lapadula G, Galeazzi M, Iannone F, Cantarini L.

Mediators Inflamm. 2014;2014:948154. Epub 2014 Jul 15. Review.

PMID:
25132737
[PubMed - as supplied by publisher]
Free PMC Article
3.

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register.

Sebastiani M, Anelli MG, Atzeni F, Bazzani C, Farina I, Fedele AL, Favalli EG, Fineschi I, Cino N, Dal Forno I, Gasparini S, Cassarà E, Giardina R, Bruschi E, Addimanda O, Cassone G, Lopriore S, Sarzi-Puttini P, Filippini M, Pignatti F, Gremese E, Biggioggero M, Manganelli S, Amato G, Caimmi C, Salaffi F, Iannone F, Ferri C; On behalf of Gruppo Italiano di Studio sulle Early Arthritides (GISEA), Sandri G, Lapadula G, Gorla R, Govoni M, Ferraccioli G, Marchesoni A, Galeazzi M, Foti R, Carletto A, Cantini F, Triolo G, Epis OM, Salvarani C.

Joint Bone Spine. 2014 Jul 28. pii: S1297-319X(14)00160-2. doi: 10.1016/j.jbspin.2014.06.011. [Epub ahead of print]

PMID:
25082646
[PubMed - as supplied by publisher]
4.

Epidural hematoma with detachment of the dural sinuses.

Lapadula G, Caporlingua F, Paolini S, Missori P, Domenicucci M.

J Neurosci Rural Pract. 2014 Apr;5(2):191-4. doi: 10.4103/0976-3147.131680.

PMID:
24966568
[PubMed]
Free PMC Article
5.

ECMO: an alternative support for acute respiratory failure caused by tuberculosis?

Cogliandro V, Lapadula G, Bandera A, Muscatello A, Marcolin R, Abbruzzese C, Rona R, Gori A.

Int J Tuberc Lung Dis. 2014 Jul;18(7):879-81. doi: 10.5588/ijtld.13.0752.

PMID:
24902570
[PubMed - in process]
6.

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.

Spadaro A, Lubrano E, Marchesoni A, Cauli A, Cantini F, Carotti M, D'Angelo S, Grassi W, Lapadula G, Macchioni P, Mathieu A, Punzi L, Ramonda R, Salaffi F, Salvarani C, Scarpa R, Olivieri I.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):465-70. Epub 2014 May 21.

PMID:
24850468
[PubMed - in process]
7.

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations.

Iannone F, Cantini F, Lapadula G.

J Rheumatol Suppl. 2014 May;91:41-6. doi: 10.3899/jrheum.140101.

PMID:
24788999
[PubMed - in process]
8.

Adalimumab in the treatment of immune-mediated diseases.

Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. Review.

PMID:
24774505
[PubMed - indexed for MEDLINE]
9.

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. Review.

PMID:
24774504
[PubMed - indexed for MEDLINE]
10.

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. Review.

PMID:
24774503
[PubMed - indexed for MEDLINE]
11.

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.

Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, Ladisa N, Angarano G, Lapadula G, Pan A, Esposti AD, Fabbiani M, Focà E, Scalzini A, Donato F, Quiros-Roldan E; Master Cohort Group.

PLoS One. 2014 Apr 23;9(4):e94768. doi: 10.1371/journal.pone.0094768. eCollection 2014.

PMID:
24760049
[PubMed - in process]
Free PMC Article
12.

Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.

Cantarini L, Lopalco G, Vitale A, Coladonato L, Rigante D, Lucherini OM, Lapadula G, Iannone F.

Clin Rheumatol. 2014 Apr 15. [Epub ahead of print]

PMID:
24733249
[PubMed - as supplied by publisher]
13.

A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy.

Notarnicola A, Iannone F, Lopalco G, Covelli M, Lapadula G.

Reumatismo. 2014 Mar 17;65(6):298-301. doi: 10.4081/reumatismo.2013.727.

PMID:
24705034
[PubMed - in process]
14.

Intra-articular therapy with tumor necrosis factor-α antagonists: an update.

Bello S, Bonali C, Serafino L, Rotondo C, Terlizzi N, Lapadula G.

Reumatismo. 2014 Mar 14;65(6):257-63. doi: 10.4081/reumatismo.2013.721.

PMID:
24705028
[PubMed - in process]
15.

Mycobacterium tuberculosis Beijing family: analysis of the epidemiological and clinical factors associated with an emerging lineage in the urban area of Milan.

Zanini F, Carugati M, Schiroli C, Lapadula G, Lombardi A, Codecasa L, Gori A, Franzetti F.

Infect Genet Evol. 2014 Jul;25:14-9. doi: 10.1016/j.meegid.2014.03.021. Epub 2014 Mar 30.

PMID:
24694826
[PubMed - in process]
16.

Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.

Punzi L, Lapadula G, Mathieu A.

BioDrugs. 2014 Apr;28 Suppl 1:25-37. doi: 10.1007/s40259-013-0065-y.

PMID:
24687236
[PubMed - in process]
17.

Serum amyloid-A in Behçet's disease.

Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R, Denaro R, Galeazzi M, Punzi L, Iannone F, Lapadula G, Simpatico A, Marrani E, Costa L, Cimaz R, Cantarini L.

Clin Rheumatol. 2014 Aug;33(8):1165-7.

PMID:
24659331
[PubMed - in process]
18.

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.

Fiorino G, Girolomoni G, Lapadula G, Orlando A, Danese S, Olivieri I; SIR, SIDeMaST, and IG-IBD.

Autoimmun Rev. 2014 Jul;13(7):751-5. doi: 10.1016/j.autrev.2014.02.004. Epub 2014 Mar 19. Review.

PMID:
24657898
[PubMed - indexed for MEDLINE]
19.

Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life.

Iannone F, Notarnicola A, Lopalco G, Lapadula G.

Joint Bone Spine. 2014 Mar 20. pii: S1297-319X(14)00033-5. doi: 10.1016/j.jbspin.2014.01.012. [Epub ahead of print] No abstract available.

PMID:
24656742
[PubMed - as supplied by publisher]
20.

Polymerization of ethylene by silica-supported dinuclear Cr(III) sites through an initiation step involving C-H bond activation.

Conley MP, Delley MF, Siddiqi G, Lapadula G, Norsic S, Monteil V, Safonova OV, Copéret C.

Angew Chem Int Ed Engl. 2014 Feb 10;53(7):1872-6. doi: 10.1002/anie.201308983. Epub 2014 Jan 21.

PMID:
24505006
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk